However, paradoxically, a subgroup of isHCCs with high EBV-positivity in tumor-infiltrating lymphocytes demonstrated poorer recurrence free and overall survival as well as higher enrichment scores for CD8+ T cell exhaustion (50). This evidence concerns the gene CD8A and neoplasm.